The Double Face of Exosome-Carried MicroRNAs in Cancer Immunomodulation
Open Access
- 13 April 2018
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 19 (4) , 1183
Abstract
In recent years many articles have underlined the key role of nanovesicles, i.e., exosomes, as information carriers among biological systems including cancer. Tumor-derived exosomes (TEXs) are key players in the dynamic crosstalk between cancer cells and the microenvironment while promote immune system control evasion. In fact, tumors are undoubtedly capable of silencing the immune response through multiple mechanisms, including the release of exosomes. TEXs have been shown to boost tumor growth and promote progression and metastatic spreading via suppression or stimulation of the immune response towards cancer cells. The advantage of immunotherapeutic treatment alone over combining immuno- and conventional therapy is currently debated. Understanding the role of tumor exosome-cargo is of crucial importance for our full comprehension of neoplastic immonosuppression and for the construction of novel therapies and vaccines based on (nano-) vesicles. Furthermore, to devise new anti-cancer approaches, diverse groups investigated the possibility of engineering TEXs by conditioning cancer cells’ own cargo. In this review, we summarize the state of art of TEX-based immunomodulation with a particular focus on the molecular function of non-coding family genes, microRNAs. Finally, we will report on recent efforts in the study of potential applications of engineered exosomes in cancer immunotherapy.Keywords
Funding Information
- Bando giovani ricercatori 2012 (GR-2011-02351557)
- TRANSCAN-2-(JTC 2016)
This publication has 135 references indexed in Scilit:
- Biochemical and biological characterization of exosomes containing prominin-1/CD133Molecular Cancer, 2013
- Characterization of human plasma-derived exosomal RNAs by deep sequencingBMC Genomics, 2013
- Unidirectional transfer of microRNA-loaded exosomes from T cells to antigen-presenting cellsNature Communications, 2011
- Macrophage Diversity Enhances Tumor Progression and MetastasisCell, 2010
- Molecular mechanism of multivesicular body biogenesis by ESCRT complexesNature, 2010
- Immunity, Inflammation, and CancerCell, 2010
- Polarization of Tumor-Associated Neutrophil Phenotype by TGF-β: “N1” versus “N2” TANCancer Cell, 2009
- Tumor‐derived microvesicles in sera of patients with head and neck cancer and their role in tumor progressionHead & Neck, 2009
- Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkersNature Cell Biology, 2008
- RETRACTED: MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancerGynecologic Oncology, 2008